For example, available studies reported that the VEGF level is associated with a progressive loss of cognitive functioning in patients with AD, where the VEGF expression in the hippocampus of patients with AD at different stages of progression was barely detectable in the normal hippocampus, but was significantly increased during the early stage of patients with AD [51]. Here, VEGFA is linked to Alzheimer disease.